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In a  previous study of murine delayed-type hypersensitivity  (DTH) 1 we suggested 
that the release of serotonin  (5-hydroxytryptamine)  (5-HT)  by local tissue mast cells 
was  required  for  the  elicitation  of these  responses  (1).  We  noted  that  DTH  was 
preferentially  elicited  in  those  cutaneous  sites  that  were  especially  rich  in  5-HT- 
containing mast cells, and that administration of the 5-HT-depleting agent, reserpine, 
abolished the ability to elicit DTH. Because the effect of reserpine could be prevented 
by administration  of a  monoamine oxidase  (MAO)  inhibitor,  the attribution  of the 
action of reserpine  to depletion  of a  monoamine  (such as 5-HT) was confirmed  (1). 
Subsequent  studies, which have employed two additional and independent  pharma- 
cological maneuvers  (5-HT tachyphylaxis of the vasculature [2] and the use of 5-HT 
antagonists2), have been consistent with our hypothesis that in murine DTH, specifi- 
cally sensitized T  cells interact with tissue mast ceils leading to the release of 5-HT, 
which acts on the local endothelium allowing the emigration of bone marrow-derived 
leukocytes from the  intravascular  to the extravascular  space  (3).  The current  study 
was  undertaken  to  test  our  hypothesis  by  determining  if we  could  obtain  direct 
evidence for activation of mast cells to release 5-HT during murine DTH. 
Materials  and Methods 
Immunization and Skin Testing (Challenge).  BDFI mice (The Jackson Laboratory, Bar Harbor, 
Maine)  received an optimal immunization for the eticitation of DTH (0.2 ml of 0.01% sheep 
erythrocytes [SRBC]; [Colorado Serum Labs, Boulder, Colo.] diluted in sterile  saline)  (4). 4 d 
later,  the animals were tested for DTH by injecting 0.03 ml of 20% SRBC into the ventral 
surface of a rear footpad. The thickness of the footpad was measured with a micrometer before 
and after challenge with antigen, and the percent change calculated (5). Immunized controls 
were challenged by footpad injection of 0.03  ml saline.  Nonimmunized controls received an 
intravenous injection of saline on day 0 and were tested by footpad injection of 20% SRBC on 
day 4. In some experiments, contact hypersensitivity reactions were elicited in the skin of the 
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ear by applying a  drop of 0.2%  dinitrofluorobenzene (DNFB)  (Eastman Organic Chemicals, 
Eastman  Kodak Co.,  Rochester,  N.  Y.)  in  4: I  acetone:olive oil 5  d  after immunization by 
contact painting with DNFB (1). 
Cell Transfer ofDTHand Cyclophosphamide Treatment.  The harvest of spleen cells, fractionation 
on  nylon-wool columns, cell transfers of DTH, and treatment with cyclophosphamide were 
done as described previously (4-6). 
Electron Microscopy.  Mice were killed at 6 or 18 h  after challenge. Additional immunized 
mice were used to verify that strong 24- and 48-h macroscopic reactions occurred after SRBC 
challenge. Mice were killed by cervical dislocation, their feet were then severed, and quickly 
immersed in Karnovsky's fixative (1% gluataraldehyde [EM Sciences, Fort Washington, Pa.] 
and 2% formaldehyde generated from paraformaldehyde buffered with 0. I M  sodium cacodyl- 
ate [ICN, Life Sciences Division, K  and K  Laboratories, Plainview, N. Y.]  at pH  7.3).  Skin 
from  the  dorsal  foot  was  excised,  cut  into  l-ram  pieces,  and  placed  for  4-5  h  at  room 
temperature in the fixative that contained sucrose which was added to bring the final osmolarity 
of the buffer to 310 mosm/liter. Tissues were then washed overnight in 0.1 M sodium cacodylate 
buffer that contained sucrose. The osmolarity of the buffered fixative was found to be very 
critical in preserving the uitrastructure of mast cells in the skin of the foot of mice. Specimens 
were  post-fixed in  buffered  1% OsO4  (Polysciences, Warington,  Pa.),  stained en  bloc with 
uranyl acetate (Fisher Scientific Co., Pittsburgh, Pa.), dehydrated in a graded series of ethanols, 
and embedded in Epon 812  (Ladd Research Industries, Inc., Burlington, Vt.). Sections were 
stained with uranyl acetate and lead citrate and examined in a  Zeiss EMI0 (Carl Zeiss, Inc., 
New  York)  or JEOLCO  JEM  100C  (JEOL  USA,  Electron  Optics  Div.,  Medford,  Mass.) 
electron microscope. 
Drugs Affecting Vasoactive Amines.  In some experiments, mice were injected intraperitoneally 
with  the  monoamine-depleting drug reserpine  (5  mg/kg)  (scrpasil for parenteral injection; 
Giba-Geigy Corp.  Pharmaceuticals Div., Summit,  N. J.)  18  h  before skin  testing.  In other 
experiments, cyproheptadine (a competitive antagonist of 5-HT and histamine; Merck Sharp 
& Dohme Research Labs, West Point, Pa.) was injected subcutaneously at a dose of 0.3 mg in 
0.5 ml saline at 6-h intervals, beginning 3 h before challenge with antigen. 
Vascular Tracers 
FLUORESCZmATED OEXTRANS (LmHT MmROSCOPY).  Fluoresceinated dextran (150,000  dalton; 
Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.), 80 mg/ml saline in a 
dose of 0.2 ml, was administered intravenously. Mice were injected with the tracer 18 h after 
challenge and  were then  killed 15,  30,  and  60  rain  later. The  animals did not exhibit any 
symptoms of distress after injection of this tracer. Tissues were excised and  fixed in 0.1  M 
phosphate-buffered saline that contained 5% formaldehyde. Tissues were cleared in glycerine 
for 48 h, mounted in glycerine on slides, and viewed with a Leitz fluorescence microscope (E. 
Leitz, Inc.,  Rocldeigh,  N. J.)  equipped with  vertical illumination, TK  400  dichroic beam 
splitting mirror, and a K520 suppression filter (E. Leitz, Inc.). 
COLLOIDAL CAm30~ (ELECTRON MICROSCOPY).  Mice were injected intravenously with colloi- 
dal carbon (Pelikan C 11/143Ia; Gunther Wagner Co., Hanover, Federal Republic of Germany) 
that contained  100 mg of carbon/ml in a  dose of 0.2 ml/100 mg of body weight, and were 
killed 1 rain after injection. The dorsal portion of the foot was quickly excised and fixed and 
processed for electron microscopy as described above. 
Radioautography.  To prevent catabolism of injected [3H]5-HT, mice were injected intraperi- 
toneally  with  the  MAO-inhihitor  pargyline  (100  mg/kg,  Abbott  Diagnostics,  Diagnostic 
Products, North Chicago, Ill.). Mice were challenged by injection of SRBC into their footpads 
2 h  later. Animals received [SH]5-HT (1.2  mCi/mouse,  16 Ci/mmol; New England Nuclear, 
Boston,  Mass.)  intraperitoneally 1 h  before challenge and  then  were killed 6  or  18  h  after 
challenge. The dorsal footpad skin was removed into formaldehyde-glutaraldehyde and proc- 
essed as above into Epon.  Radioautographs were made from  1-~tm sections placed on  glass 
slides that  had  previously been  coated with  an  adhesive chromium-alum-gelatine mixture. 
Slides were coated with Ilford L4 photographic emulsion (Polysciences) by dipping and were 
exposed in light-tight boxes over drierite at 0-4°C for 1-2 wk. Radioautographs were developed 
with Kodak D-19 (Eastman Kodak Co., Rochester, N. Y.),  fixed, stained with toluidine blue, 
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Results 
Depletion of [3H]5-HT  from Mast Cells in DTH.  In a previous study of normal mice~ 
we found that in the skin of the footpads radioactive 5-HT was exclusively localized 
to  mast  cells  (Fig.  1 of reference [1]).  In  the  present  study,  radioautography was 
performed 6  and  18  h  after footpad challenge of mice  injected systemically with 
[~H]5-HT before challenge to determine if changes in the content of 5-HT in mast 
cells  occurred  in  DTH.  6  h  after  challenge  with  SRBC,  there  was  comparable 
accumulation of silver grains over the cytoplasm of mast cells in control and immune 
mice (similar to Fig. 1 a and b). Other cell types in the dermis were not labeled, except 
for occasional intravascular platelets. 
At  18 h, mast cells from controls were still completely covered with silver grains 
(Fig.  1 a and b), whereas immunized and challenged mice showed fewer silver grains 
(Fig.  1 c,  d,  e,  and  f). This  revealed metachromasia  in  the  granules  that  was  not 
evident in heavily labeled controls. Some mast ceils had a small number of residual 
silver grains over them, suggesting that these cells had not completely released their 
5-HT  content.  Thus,  light  microscopic  radioautography  confirmed  that  5-HT  is 
released from dermal and hypodermal mast cells in DTH. 
Ultrastructure of Mast Cells in the Footpads of Control Mice.  Mast cells were frequently 
found in close proximity to blood vessels  in the papillary and reticular layers of the 
dermis, as well as in the subcutaneous tissues. In nonimmune and unchallenged mice, 
mast  cells were  similar  in  appearance  to  those  of nonimmune  controls that  were 
challenged with SRBC and examined 6 or 18 h later, and thus are described together. 
Dermal mast  cells were large  (20-30 #m)  and oval shaped with numerous short 
surface  filopodia  and  characteristic  dense  cytoplasmic  granules  surrounded  by  a 
closely fitting plasma membrane (Fig. 2). The granules were highly osmiophilic and 
homogenous in shape and density, a  feature characteristic of 5-HT-containing mast 
cells (7). A few granules were surrounded by a small perigranular space between the 
granule  matrix  and  granule  membrane.  Some  variation  in  the  size  and  electron 
density of individual granules was observed, but disintegration of granules in mast 
cells from control mice was very infrequent (Table I). The filopodia at the surface of 
these mast cells were in close apposition to the cell surface membrane (Fig. 2). 
Early Ultrastructural Alterations of Mast Cells in DTH.  4 d after immunization and 6 
h after footpad challenge with SRBC, no increase in footpad thickness was detectable. 
However, ultrastructurally,  an  early and  consistent change in  local mast  cells was 
surface activation that consisted of the extension of filopodia (Figs.  3 and 4 a). At 6 h 
after challenge,  many  mast  cells  that  demonstrated  surface  activation  showed  no 
alteration in appearance of granules. These granules were rather closely housed by 
the  perigranular  membrane;  however, a  number of ceils showed signs  of granule 
Fio.  1.  Light microscopic radioautographs of the dermis of the skin of the footpads of mice injected 
with [SH]5-HT. The animals were also injected with the monoamine oxidase inhibitor pargyline to 
prevent catabolism of [SH]5-HT.  The skin was removed  18 h  after injection of SRBC to nonim- 
munized or immunized mice. 
(a and b) Nonimmune controls; (c, d, e, and f) immune mice. Note the much lower intensity of 
labeling of the mast cells from the immunized animals. In the controls that were similarly challenged 
with SRBC, the overlying silver grains are so numerous that  the metachromasia of the mast cell 
granules is obscured. In immunized and challenged mice, the reduction in radiolabeling allows the 
granules to be seen (compare b and f). All mast cells are heavily labeled in controls. The degree of 
depletion of labeling of mast cells after challenge of immunized mice is variable (compare c and d 
with e and f). The marker bar in each figure is 25/~m in length. 1361 1362  MAST  CELL  ACTIVATION  IN  DELAYED-TYPE  HYPERSENSITIVITY 
FIO.  2.  An electron micrograph of a dermal mast cell from the footpad skin of an immunized but 
unchallenged mouse. The electron-dense granules of the cell are stained homogeneously. Occasion- 
ally, perigranular spaces can be seen (arrowheads). The surface filopodia (single arrows) appear 
flaccid and their distal tips lie in close proximity to the plasma membrane of the mast cell. ×  7,200. 
TABLE  I 
Morphomet~y of Degranulating Mast Cells in DTH* 
Electronmicrograph from 
No. of gran-  Total No.  No. of nor-  ules/mast  No. of  of 
mal gran-  cell demon- 
mast cells  granules/  ules:~/mast  strating dis- 
counted  mast cell ±  cell 4- SE  solution§ 4-  SE  SE 
Immunized and SRBC-challenged mice  25  52.4 4- 5  13.4 4- 2.6  39.0 4- 5.4 
Control mice (immunized and not challenged  25  67.7 4- 3  67.0 4- 3.2  0.72:1:0.2 
or challenged only) 
* Granules were counted and evaluated in mast cells that had a cross section of their nucleus included in 
the plane of section and that were photographed at a magnification of 8,000. 
:~ The matrix of normal granules is homogeneously stained. 
§ Dissolution of homogenous matrix of granule core, leading to heterogeneity of staining. 
release.  These  included  fusion  of  granules  with  each  other  and  with  the  plasma 
membrane.  The  affected  granules  showed  dissolution  of their  matrices  so  that  the 
homogeneous  osmiophilia  of the granular  matrix  was replaced  by a  coarse stippling 
of material.  (Fig.  3,  inset).  These  changes,  which  were seen more  extensively at  18 h 
(Table I)  (see below), were noted  in less than  one-half the mast cells examined  at 6  h, 
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Fro. 3.  A dermal mast cell from the tootpad skin of an immunized mouse obtained 6 h after 
challenge with SRBC. Note the erection of the surface filopodia (arrows). The mast cell granules 
generally retain their homogeneous staining. ×  11,000. Inset: occasional mast cells, even at 6 h, 
show fusion of granules with each other and apparent exocytosis  (arrow). Inset × 18,000. 
Later Stages of Mast Cell Activation in DTH.  Almost all mast cells were in  various 
stages of obvious degranulation  in  skin obtained  from immunized mice  18  h  after 
footpad challenge (Table I). Degranulation seemed to proceed in a  sequence of steps 
(Figs. 4 and 5). At first, the granules enlarged and became reduced in electron density 
(dissolution). The plasma membrane of the granules sometimes showed even greater 
expansion, resulting in  an open space between the  granule  and  perigranular  mem- 
brane  (Fig.  4).  Granule  enlargement  was  followed by coalescence of granules with 
eventual  fusion  of their  perigranular  membranes  (Figs.  4b  and  5 a).  These  fused 
granules had a matrix that exhibited swelling, and even greater loss of electron density 
(disintegration)  (Fig.  5).  As  the  granule  matrix  disintegrated,  discrete  particles  re- 
placed the formerly homogenous electron density. Occasionally, fusion of the granule 
membrane  with  plasma  membrane  was  observed  (Fig.  5b).  The  coalescence  of 
granules  resulted  in  great  expansion  of apparent  diameter  of granules,  led  to  a 
decrease in their number (Table I), and to the formation of long-branched intracellular 
channels. 
Not  all  granules  of individual  mast  cells were  at  the  same stage of dissolution. 
Granules with an electron density between that of normal granules and that of altered 
granules  could  at  times be seen  (Figs.  4  and  5).  These were found  close to altered 
granules  as  well  as  close  to  completely  normal-appearing  granules.  The  altered F1o.  4.  Electron micrographs of portions of" the cytoplasm of mast ceils from the dermis of the skin 
of immunized mice obtained  18 h  after challenge with SRBC.  (a)  Several granules have lost the 
homogeneous electron density of the cores (arrows).  Erection  of surface filopodia  (arrowheads)  is 
still evident, and the plasma membrane surrounding the cell remains intact. Numerous microfila- 
ments (mf)  and  vesicles are  present  in  the cytosol.  ×  28,800.  (b)  Two granules (arrows),  in  the 
cytoplasm of the same cell shown in  (a)  have fused with one another. Dissolution of the matrix of 
these granules is pronounced. X 45,000. 
1364 Fro.  5.  Electron micrographs of mast cells from the dermis of the footpad skin of immunized mice 
obtained  18 h  after challenge with SRBC.  (a)  Fusion of granules has produced enlarged cavities. 
The matrix of these granules shows advanced dissolution. Only some of the granules are affected; 
however, there is no restriction of the process to any given region of the cell. The largest cavities 
(arrows) tend to occur near the plasma membrane. Extension of surface filopodia is again notable. 
×  11,340.  (b)  Apparent  exocytotic fusion  of a  mast  cell  granules  with  the  plasma  membrane 
(arrowhead). ×  28,800. 
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granules did not seem to occupy a  fixed position in the cell. Such granules were found 
at the periphery as well as toward the center of the cell. Even in occasional mast cells 
that  had  undergone  nearly  complete  degranulation,  the  nucleus  and  cytoplasmic 
membrane remained intact and the cell retained its original shape, sugesting that this 
was degranulation by exocytosis, rather than cytolysis; but a few mast cells were noted 
to be  disrupted  by a  cytolytic process.  Actual extrusion  of altered  granules  into the 
extracellular space was infrequently observed in DTH. 
Ultrastructure of Blood  Vessels in  Control Mice.  Postcapillary  venules  in  the  dermis 
and hypodermis of the footpad skin of challenged normal mice, or in immunized but 
not challenged mice, contained high endothelial walls held together by tight junctions 
(Fig. 6). A  basal lamina, 50-60 nm thick, adhered to the endothelial wall and formed 
a  continuous layer around  the endothelium,  which split  to enclose the pericyte but 
separated  the venule  from the surrounding connective tissue.  Occasionally lympho- 
cytes, leukocytes, or erythrocytes were observed in the lumen of postcapillary venules 
in control animals, but these cells were not observed outside Of the vessel. 
Vascular Changes after Challenge of  Immune Mice.  Observations ofpostcapillary venules 
from the  dermis  and  hypodermis of footpads of animals  that  were immunized  and 
then  challenged  with  SRBC  4  d  later  showed  definite  changes  in  endothelial  cells. 
FIG. 6.  Postcapillary venule from the dermis ofthe footpad skin ofan immunized but unchallenged 
mouse. Tight junctions  (arrow; see inset) appear  in the region of contact between adjacent cells. 
The nucleus (n) is flattened and makes the cell surface bulge slightly into the lumen. Processes of 
pericytes are in close proximity to the endothelium and are surrounded by the basement membrane 
of the venule. × 7,600. Inset ×  15,600. P.  ASKENASE, S.  BURSZTAJN,  M.  GERSHON,  AND  R.  GERSHON  1367 
These changes were  quite  prominent  18 h  after testing.  Favorable  planes  of section 
revealed separations in the intercellular junctions of endothelial cells of postcapillary 
venules  (Figs.  7  and  9).  This  resulted  in  wide  gaps  (0. I-1.0 #m)  between  cells.  At 
times, endothelial cell cytoplasm was reduced to a  thin membrane, resembling that of 
the endothelia  of fenestrated  capillaries.  In a  fortunate  plane  of section,  leukocytes 
were seen to be migrating by diapedesis  through these endothelial  gaps (Fig. 9). 
Topology of the  Vasculature As Envisaged by Fluoresceinated Dextrans.  To examine  the 
potential  effect  of mast  cell-released  mediators  on  the  local  vasculature,  mice were 
injected intravenously with fluoresceinated dextran.  This permitted viewing by fluo- 
rescence microscopy of  the entire skin of  the ear under various experimental conditions, 
with the vascular tree intact. This tracer was found particularly suitable for examining 
possible vascular leaks, because the dextran particles are small enough not to be held 
back by the  filtering  effect of the endothelial  basal  lamina,  and  thus  extravascular 
accumulation outside of the blood vessels was made evident by diffuse green fluores- 
cence. 
Fig.  8 a  shows the tracer confined to the blood  vessels  in  mice that  were contact 
sensitized  with  DNFB  but  not challenged  in the ear skin with  DNFB.  The  fluores- 
ceinated  dextran  outlined  the  lumena  of veins,  venules,  postcapillary  venules,  and 
capillaries,  but  was  not  seen  outside  of blood  vessels.  A  variety  of blood  cellular 
elements were noted to permeate the vascular lumen. A similar result was obtained  18 
FIo.  7.  Two neutrophils  (N)  occupy the lumen of a postcapillary venule in the dermis of the 
footpad skin of  a mouse that was immunized and killed 18 h after challenge with SRBC. One of the 
neutrophils extends pseudopods toward the endothelial wall. Separation of the junction  between 
two endothelial cells can be seen (arrow). × 22,500. 1368  MAST CELL ACTIVATION IN  DELAYED-TYPE  HYPERSENSITIVITY 
FIG. 8.  Fluorty~ence micrographs from the dermis of the ear skin of mice contact sensitized with 
DNFB .5 d previously and injected intravenously with fluoresceinated dextran 17 min before killing. 
Co, c, and d) Micrographs from animals challenged 18 h previously by contact painting with DNFB, 
whereas  (a)  is from an unchallenged  mouse. (c and d) Micrographs  from animals  treated with 
reserpine and cyproheptadine,  respectively. Extravasation  of the vascular tracer into the extravas- 
cular space is noted in the immunized  and challenged  animal Co), whereas the tracer is strictly 
confined within  the vessels in immunized,  but unchallenged  animals  (a), and also in immunized 
and challenged animals that were treated with reserpine (c) or cyproheptadine  (d). All X 80. 
h  after DNFB challenge to the ears of nonimmune  mice. However, when  tracer was 
injected into mice that  were  immunized  and  their ears skin tested with  DNFB  5  d 
after sensitization, a  large  amount  of extravasation  of fluoresceinated dextran  was 
evident outside of the blood vessels (Fig. 813).  The extravascular appearance of the 
tracer was seen as early as 1 min after the injection of tracer, which was performed 18 
h  after challenge. At some points, permeation of extracellular spaces with tracer was 
so severe as to obscure visualization of the neighboring blood vessels (Fig. 8 b). When 
tracer was  injected into  mice that  were similarly sensitized and  tested with  DNFB, 
but which were injected with the monoamine-depleting drug reserpine or with the 5- 
HT  antagonist cyproheptadine, there was no extravasation of tracer (Fig. 8 c  and d). 
Thus, treatment of mice with reserpine or with cyproheptadine resulted in prevention 
of blood vessel leaks in contact hypersensitivity. 
Ultrastructural  Identification  of Leaky  Blood  Vessels.  To  confirm  that  vascular  leaks 
resulted  from  separation  of endothelial  cells, colloidal carbon  was  employed  as  a 
tracer that was visible at the ultrastructural level. Carbon particles were noted entirely 
confined to the lumen of postcapillary venules in immunized, but unchallenged, mice. 
In  contrast,  many  carbon  particles  were  found  outside  the  endothelial  lumen  of 
postcapillary venules in footpad skin taken from  immunized mice that were killed 5 P.  ASKENASE, S.  BURSZTAJN,  M.  GERSHON,  AND  R.  GERSHON  1369 
min after colloidal carbon injection  and  18 h  after SRBC challenge  (Fig. 9).  In fact, 
many  more  particles  were  outside  the  endothelium  than  inside  the  vessel  lumen. 
Diapedesis  of cells  through  the  open  gaps  were  also seen  at  sites  of penetration  of 
tracer into the tissue  (Fig. 9). The pericytes and the basal lamina served as a  partial 
barrier to the further diffusion of carbon particles beyond the endothelial wall. 
T Cell Dependence of Mast Cell Activation and Endothelial Gap Formation in DTH.  Mast 
cell activation  and  endothelial  cell changes seen  in actively sensitized  animals were 
also demonstrated  in recipients of spleen cells from immunized donors (Table II). In 
further  studies,  cells  used  for transfers  were  fractionated  with  nylon-wool columns. 
The  fraction  of nonadherent  non-immunoglobulin-bearing  lymphocytes that  trans- 
ferred DTH reactions was also found capable of transferring to recipients the capacity 
for mast  cell  activation  that  inelucled  filopodial  extension  and  degranulation  (Fig. 
10);  and  the characteristic  gaps  in  the endothelium  of posteapillary  venules  (Table 
II).  It  was  concluded  that  the  mechanism  by  which  these  ultrastructural  changes 
occurred was transferable  by T  cells.  To  further  rule  out  involvement  of B  cells  in 
these  changes,  similar  uhrastructural  studies  were  undertaken  of DTH  reactions 
elicited in mice immunized with high doses of SRBC  (0.5 ml of 50% SRBC;  1 ×  109 
cells)  and  pretreated  with  B  cell-depleting  doses of cyclophosphamide  (200  mg/kg) 
Flo. 9.  A postcapillary venule from the footpad skin of an immunized mouse killed 18 h after 
challenge, and 5 rain after injection of colloidal carbon. Parts of the foot process of a leukocyte (L) 
(probably a nentrophil) are seen leaving the vascular lumen through a gap that has opened between 
endothelial cells (arrows). Note that many of the carbon particles have entered the gap between 
endothelial cells; however, the carbon remains confined (probably by the basal lamina) and can be 
seen between the processes of pericytes (P). X 16,000. 1370  MAST  CELL  ACTIVATION IN  DELAYED-TYPE  HYPERSENSITIVITY 
TABLE  II 
T Cell Dependence of Mast Cell and Endothelial Cell Changes in Murine DTH 
Group  Immunization 
Gaps at 
Footpad  Mast cell  endothe- 
swelling at  degranu-  lial cell 
18 h  lation 
junctions 
A 
B 
(3 
D 
E 
F 
G 
% 
0.2  ml of0.01% SRBC intravenously (2 X  l0  s SRBC)  35  +  + 
Recipients of unfractionated immune spleen cells  34  +  + 
Recipients of unfractionated normal spleen cells  12  -  - 
Recipients of nylon nonadherent sensitized spleen cells  25  +  + 
0.5 ml of 50% SRBC (I ×  109 SRBC)  9  -  - 
0.5 ml of 50% SRB(2  +  cyclophosphamide 200 mg/kg at  26  +  + 
day -2 
Nonimmune controls  10  -  - 
Summary table of three separate experiments in which 6-wk-old BDF1 male mice were actively sensitized 
(groups A, E, and F) by intravenous injection of SRBC at day 0 and were footpad tested with SRB(2  on 
day 4, or received spleen cells  from actively sensitized (groups B and D) or normal donors (group (2)  (all 
transfers were at a ratio of one donor:one recipient) on day 4 and were footpad tested with SRB(2  on day 
5.  In each experiment there were five to six mice/group, and electron microscopy was performed on the 
footpad skin of three or four mice/group. 
FIG.  10.  A  mast cell  from the  dermis of the  footpad skin of a  normal mouse that  received  an 
intravenous transfer of nylon-nonadherent splenic lymphocytes from mice immunized with SRB(2. 
The animal was killed  18 h  after challenge with SRB(2.  The cell  shows erected surface filopodia 
(arrowheads). Dissolution and fusion of granules (arrows) are also evident. ×  10,000. P.  ASKENASE,  S.  BURSZTAJN,  M.  GERSHON,  AND  R.  GERSHON  1371 
(5).  Similar to the DTH response of animals noted above, DTH responses of these 
animals  (which  had  no  detectable antibody or  B  cells)  showed  mast  cell  surface 
activation and degranulation and, also, the gaps between endothelial cells of postcap- 
illary venules (Table II). Thus, it was concluded that these changes were T  cell, and 
not B cell, dependent in DTH. 
Discussion 
Three independent pharmacological treatments employed in previous studies and 
discussed earlier have indicated that local release of 5-HT is required to elicit DTH 
in  mice  (1-3).  This evidence indicated  that  endogenous release of 5-HT probably 
occurs  in  DTH,  and  that  the  site  of action  of released  5-HT  may  be  the  local 
vasculature. It seemed likely that the action of 5-HT is to alter local endothelial cells 
to permit diapedesis of bone marrow-derived leukocytes. 
The current study has demonstrated that local mast cells are activated during the 
evolution of DTH responses and  that  this activation is accompanied by exocytosis 
and consequent release of 5-HT. Thus, the surfaces of the mast cells exhibit extension 
of filopodia and  their granules can be seen to fuse with one another and with the 
plasma  membrane during DTH to create tortuous channels within the cells. These 
channels  are  open  to  extracellular  fluid,  and  release of granular  content  is  made 
apparent by dissolution of granular matrices. Although mast cells that were degran- 
ulating by exocytosis exhibited surface activation of filopodia, as previously noted in 
anaphylactic antibody-mediated degranulation of basophils (8, 9), massive extrusion 
of granules from the cells, as occurs in anaphylactic degranulation of basophils or in 
rat mast cells (10), was rarely observed. 
Radioautographic experiments with [aH]5-HT showed that 5-HT is depleted from 
skin mast cells in DTH, confirming its release during exocytosis (Fig.  1). Moreover, 
there is also an alteration ofpostcapillary venules during DTH. This change, involving 
the  formation  of gaps  between junctions  of endothelial  cells,  is  identical  to  the 
previously  described  action  of 5-HT  in  this  species  (11).  Ultrastructural  studies 
revealed that colloidal carbon tracer and leukocytes moved out of the vessels through 
these endothelial gaps  (Fig. 9). Studies with fluorescein-conjugated dextran demon- 
strated that these vascular changes are indeed dependent on release of 5-HT. Vascular 
permeability in DTH was blocked by pretreatment with reserpine (to deplete 5-HT), 
or by cotreatment with cyproheptadine (to antagonize the interaction of 5-HT with 
endothelial receptors) (Fig. 8). Because mast cell and endothelial cell alterations were 
also noted in recipients of an enriched T  cell fraction of sensitized ceils and were also 
noted  in  actively sensitized  animals  that  were  severely depleted  of B  cells,  these 
changes are probably T  cell dependent  (Table II). Ultrastruetural  identification of 
mast  cell  degranulation  and  endothelial  cell  activation  in  DTH  of humans  (12) 
suggest that an analogous process may be involved in cell-mediated reactions of this 
species. 
A unifying hypothesis to draw our findings together with other published findings 
is as follows: DTH responses are probably mediated by specifically sensitized T  cells 
of the Ly 1  ÷ phenotype (13) that normally enter the tissues from the recirculating pool 
in the blood. When these Lyl  + T  cells encounter antigen, they release a  variety of 
lymphokine-like factors  (14), among which  those with ehemotactic and  migration- 
inhibiting activities may be most relevant to DTH. However, the elaboration of these 1372  MAST CELL ACTIVATION IN DELAYED-TYPE HYPERSENSITIVITY 
factors is necessary, but not sufficient, for the elicitation of DTH. In addition,  there 
must be diapedesis of bone marrow-derived accessory leukocytes through endothelial 
gaps in response to the net chemotactic forces elaborated by the T  cells. Our findings 
support the view that T  cells in murine DTH interact with local mast cells, leading 
to mast cell activation and release of 5-HT, which  in turn causes the separation of 
endothelial cells to allow diapedesis of effector cells. Thus, there is a 5-HT-dependent 
diapedesis in murine DTH. 
It  still  remains  an  open  question  as  to  whether  degranulation  by  exocytosis  is 
required for the release of the 5-HT, which is important in the elicitation of DTH. It 
should be considered that release of sufficient 5-HT to elicit DTH may proceed via 
an  additional  release  mechanism  that  might  be  accompanied  by  less  prominent 
exocytosis. In this regard, we have recently demonstrated that murine mast cells can 
secrete  5-HT  in  the  presence of inhibited  histamine  release and  in  the  absence of 
overt degranulation  (15). 
The  results  of the  current  and  previous  studies  make  it  highly  likely  that  the 
degranulation  and 5-HT release leading to endothelial  changes is T  cell dependent 
and is not mediated by an intermediary B cell product such as IgE antibody. In the 
actively  sensitized  animals  challenged  at  4  d,  there  is  little  evidence  for  B  cell 
activation as measured by serum antibody (4), plaque-forming cells (16), or antigen- 
binding rosette-forming B cells (6). Moreover, mice that are treated with anti-mu sera 
and are rendered agammaglobulinemic and unable to make antibody responses have 
intact DTH (17,  18). The mast cell and endothelial changes we have noted in DTH 
are seen  in  recipients  of an  enriched  T  cell  fraction of sensitized cells,  and similar 
changes  are seen  in  animals treated with  a  high  dose of cyclophosphamide, which 
eliminates detectable B cells (Table II). However, it cannot be ruled out that a few B 
cells present in actively sensitized animals, and present in the contaminating Ig  + cells 
of the nylon-nonadherent  fraction, and resistent even to high doses of cyclophospha- 
mide could produce small, but sufficient, quantities of IgE-type antibody to act as an 
intermediary and  passively sensitize  tissue  mast  cells  (19).  Thus  the  mast cell  and 
endothelial changes we have observed could conceivably be T  cell dependent rather 
than T  cell mediated.  Further  study will  be necessary to irrefutably rule out  small 
numbers of IgE-secreting B cells in the mediation of these events. 
The demonstration that the monoamine 5-HT is released from mast cells and plays 
a crucial role in DTH by acting on vascular endothelium does not imply that this is 
the  only  action  of vasoactive amines  in  DTH.  Because  mouse  mast  cells  contain 
histamine,  it  is  probable that  this  diamine  is  also being released  in  DTH.  Murine 
vessels are insensitive to histamine (2), but regulatory T cells are known to be activated 
through  histamine-2 surface receptors  (3).  Thus,  in mice there may be a  functional 
split in the role of the two major vasoactive amines in DTH responses. The principal 
vasoactive amine of this species, 5-HT, may be released in small amounts early during 
the response, producing vascular changes, but also paralyzing receptors of endothelial 
cells so that  they become resistant  to further activation by 5-HT. Later, with more 
massive degranulation, significant amounts of histamine may also be released, which 
then signals regulatory T  cells via histamine-2 receptors, leading to suppression and 
termination of the DTH response. In conclusion, it is clear from our results that 5-HT 
release from mast cells is a prominent factor in DTH responses and this supports the P.  ASKENASE, S.  BURSZTAJN, M.  GERSHON, AND R. GERSHON  1373 
hypothesis previously established with pharmacological data that 5-HT plays a major 
role in the production and evolution of DTH responses. 
Summary 
We have previously suggested that the release of serotonin  (5-hydroxytryptamine) 
(5-HT)  by  local  tissue  mast  cells  is  required  for  the  elicitation  of  delayed-type 
hypersensitivity  (DTH)  in  mice. In the current  study,  light  microscopic radioauto- 
graphs from animals treated with [3H]5-HT indicated that local mast cells released 5- 
HT between 6 and  18 h  during the evolution of DTH. Ultrastructural examination 
of mast cells revealed surface activation, indicated by extension of surface filopodia, 
and degranulation by fusion and exocytosis. Light and electron microscopic studies of 
the endothelium of postcapillary venules at sites of DTH revealed the development of 
gaps between  adjacent  cells.  The  development  of gaps permitted  extravasation  of 
tracers  that  was  abolished  by  depletion  or  antagonism  of 5-HT.  Thus  mast  cells 
degranulated  and  released  5-HT  in  DTH,  and  this  5-HT  acted  on  local  vessels. 
Recipients of nonadherent, non-immunoglobulin-bearing sensitized lymphocytes also 
demonstrated similar mast cell degranulation and the formation of endothelial gaps. 
This indicated that mast cell degranulation  and 5-HT release in murine DTH were 
probably T  cell dependent. 
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